What is pelvic inflammatory disease?

For women, gynecological diseases are very troubling problems. There are many types of gynecological diseases clinically, and pelvic inflammatory disease is also a gynecological disease, but more people do not know what pelvic inflammatory disease is. Many women have a very high chance of suffering from pelvic inflammatory disease, and the causes of pelvic inflammatory disease are very complicated. In this case, treatment measures must be taken in a timely manner. Prevent pelvic inflammatory disease from getting worse.

1. Pelvic inflammatory disease

Pelvic inflammatory disease (PID), also known as pelvic inflammatory disease, is a group of diseases caused by inflammation of the female upper reproductive tract, including endometritis, salpingitis, tubo-ovarian abscess, and pelvic peritonitis. Most of the symptoms are mainly pain, accounting for more than 90%. Because the pelvic organs are mostly controlled by visceral nerves, the pain sensation is often not accurately located, and the inflammation itself is not confined to a certain pelvic organ. Therefore, it is sometimes difficult to determine clinically the exact location of the inflammation, whether it is the fallopian tube or ovary, etc. Sometimes, inflammation localized near the fallopian tube and ovary is called adnexitis.

2. Treatment

The main treatment is antibiotics, and surgery if necessary. Antibiotic treatment can eliminate pathogens, improve symptoms and signs, and reduce sequelae. With active treatment with appropriate antibiotics, most pelvic inflammatory disease can be completely cured. Principles of antibiotic treatment: empirical, broad-spectrum, timely and individualized. It is reasonable to select antibiotics based on susceptibility testing, but antibiotic treatment usually needs to be given before laboratory results are obtained. Therefore, initial treatment is often based on experience. Since the pathogens of pelvic inflammatory disease are mostly Neisseria gonorrhoeae, Chlamydia, and mixed infections of aerobic and anaerobic bacteria, and aerobic and anaerobic bacteria are divided into Gram-negative and Gram-positive, the choice of antibiotics should cover the above pathogens, and broad-spectrum antibiotics and combination drugs should be selected.

3. Note

Patients treated with antibiotics should be followed up within 72 hours to determine whether their clinical condition has improved. The patient's clinical symptoms should improve within 72 hours after treatment, such as a decrease in body temperature, reduced abdominal tenderness and rebound tenderness, and reduced cervical motion tenderness, uterine tenderness, and adnexal tenderness. If symptoms do not improve during this period, further examination and re-evaluation are required, and laparoscopy or surgical exploration is performed if necessary. For patients infected with Chlamydia trachomatis and Neisseria gonorrhoeae, the pathogens can be rechecked 4 to 6 weeks after treatment.